Is Charles River Laboratories International, Inc. overvalued?

Charles River Laboratories International, Inc. (CRL) looks overvalued — trading about 13% above its fair value.

Overvalued

Price

$284.35

Fair value

$248.57

Current P/E

28.4

Normal P/E

24.9

Market cap

$13.70B

Dividend yield

0.0%

Return on equity

-7.7%

Sector

Healthcare

Fair value compares CRL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks